新穎的小分子化合物之抗癌機制研究

Synthetic small molecular inhibitors of the transcription factor NF-кB suppress cell viability and induce apoptosis in cancer cells

羅福轅(Fu-Yuan Lo)

指導教授 ： 梁美智

國立交通大學/生物科技學院/分子醫學與生物工程研究所/碩士(2012年)

https://doi.org/10.6842/NCTU.2012.00756

摘要

轉譯因子NF-кB (nuclear factor kappa-light-chain-enhancer of activated B cells)在許多細胞反應 (如細胞增生、細胞凋亡、免疫及發炎反應) 的調控過程中扮演重要的角色。研究顯示NF-кB調控失常與部分腫瘤細胞的增生有關，且證實透過抑制NF-кB的過度表現，能夠有效地抑制腫瘤細胞的生長，並促進細胞凋亡。因此，轉譯因子NF-кB是一個具潛力的抗癌標靶。交通大學應用化學系孫仲銘教授的實驗室，以2-aminofuran-linked-benzimidazole為核心結構，透過修飾周邊的官能基而衍生出一系列新穎的小分子化合物。經過篩選實驗，我們發現化合物 #1412 (與其衍生物# 21026)，在微摩爾濃度範圍內，具有抗癌的生物活性，且能夠有效地抑制多種癌症細胞株內NF-кB的訊息活化與傳遞。例如，在人類T-淋巴癌細胞株Jurkat 與人類多發性骨髓瘤細胞株RPMI-8226，#1412 (與其衍生物# 21026)藉由抑制TNF-所活化的IкBα 的磷酸化反應及降解反應，進而抑制NF-кB 成員p65的細胞核遷移活動 ( nuclear translocation )，使NF-кB無法從細胞質進入細胞核內進行目標基因的轉錄反應。另外，#1412 (與其衍生物# 21026)也能夠有效地抑制此二種血液癌症細胞株的增生，並誘導細胞凋亡。總結，此實驗結果建議新穎化合物#1412 (與其衍生物# 21026) 的抗癌效果與其抑制轉譯因子NF-кB訊息傳遞的能力有關。

關鍵字

small molecular inhibitors ； NF-kappa-B ； I-kappa-B-alpha ； lymphoma ； multiple myeloma ； apoptosis

並列摘要

Transcriptional factor NF-кB plays a critical role in mediating cellular processes, including cellular growth control, apoptosis, immune and inflammatory responses.
Dysregulation of the NF-кB signaling pathway has been reported in a variety of cancer types and inhibition of the constitutive NF-кB activity may have therapeutic applications. In this study, we have identified the synthetic compounds #1412 and #21026, novel derivatives of the 2-aminofuran linked benzimidazole (synthesized in the laboratory of Prof. C.M. Sun in the Department of Applied Chemistry at National Chiao Tung University), as potent NF-кB inhibitors. Compound #1412 does- and time-dependently inhibited TNF-α induced NF-кB activation in the low micromolar range in cultured cells. In the human leukemic T cell Jurkat cell line and multiple myeloma RPMI-8226 cell line, both compounds blocked TNF-α induced IкBα phosphorylation and degradation and nuclear translocation of the NF-кB subunit p65. In addition, both compounds affected cell viability and induced cell apoptosis. Taken together, these results suggest that the anticancer activity of compound #1412 and #21026 in human cancer cells is related to inhibition of the NF-кB signaling pathway.

並列關鍵字

small molecular inhibitors ； NF-kappa-B ； I-kappa-B-alpha ； lymphoma ； multiple myeloma ； apoptosis

參考文獻

Albanese, C., Wu, K., D'Amico, M., Jarrett, C., Joyce, D., Hughes, J., Hulit, J., Sakamaki, T., Fu, M., Ben-Ze'ev, A., et al. (2003). IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Molecular biology of the cell 14, 585-599.

Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511.

Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer cell 12, 115-130.

Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., and Sonenshein, G. E. (2000). Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Molecular and cellular biology 20, 5381-5391.

Baraldi, P. G., Fruttarolo, F., Tabrizi, M. A., Romagnoli, R., Preti, D., Bovero, A., Pineda de Las Infantas, M. J., Moorman, A., Varani, K., and Borea, P. A. (2004). Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists. Journal of medicinal chemistry 47, 5535-5540.